Bronchiolitis: Evaluation of Wang's Score as a Predictor of the Duration of Oxygen Therapy in Bronchiolitis

NCT ID: NCT03362125

Last Updated: 2017-12-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

105 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-10-01

Study Completion Date

2016-02-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of Wang's score as a predictor of the duration of oxygen therapy in bronchiolitis

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Bronchiolitis is a viral disease of very variable evolution going from a simple outpatient treatment to the necessity of hospitalization in intensive care.

This epidemic disease is found all year round with a seasonal peak from mid-October to late winter.

The risk factors for progression to severe or prolonged bronchiolitis have been highlighted, but the duration of hospitalization is difficult to predict, which leads to organizational difficulties in the services and additional anxiety for the families.

The management of beds during winter epidemics can be a source of difficulties for hospitalization services, with the need to temporarily increase reception places or transfer children to other hospitals.

Oxygen rescue is the main factor limiting the discharge of the pediatric ward. This criterion seems to us more suitable than the total duration of hospitalization.

Indeed, other factors such as the family environment or food difficulties can delay the child's departure from the service. Their assessment seems to be more subjective, their assessment may vary from one doctor to another.

Better management of beds during winter epidemics could help to avoid changes in service during hospitalization, thus facilitating relationships between caregivers and families.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bronchiolitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Infants under 2 years
* Infants consulting at the emergency department of the University Hospital of Rennes for a first or second episode of bronchiolitis with criteria for hospitalization

Exclusion Criteria

* Children transferred from another department such as pediatric intensive care unit
* Children for whom Wang's score could not be established
* Child over 2 years old at diagnosis
* Child with a 3rd episode of bronchiolitis or more.
Maximum Eligible Age

2 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rennes University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sylvaine Lefeuvre

Role: PRINCIPAL_INVESTIGATOR

Rennes University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rennes University Hospital

Rennes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

35RC15_3022 BRONCHOLITE

Identifier Type: -

Identifier Source: org_study_id